GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE. International journal of medical sciences, [S. l.], v. 6, n. 4, p. 849–855, 2026. DOI: 10.55640/. Disponível em: https://www.academicpublishers.org/journals/index.php/ijms/article/view/13107.. Acesso em: 7 aug. 2026.